TrialSao Paulo medical journal = Revista paulista de medicina2014
Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study.
Regis Albuquerque Campos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.